October 13, 2025
Jacquelyn Martin/AP

STAT+ | FDA declares Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance

The move could further delay the approval of drugs made by some biotechs, including some from Scholar Rock and Regeneron Pharmaceuticals.

By Elaine Chen


CDC battered by government shutdown firings, while some are rescinded

HHS hasn’t released official numbers on the cuts, but most anecdotal reports related to health agency firings have centered around the CDC.

By Elizabeth Cooney, Chelsea Cirruzzo, and Helen Branswell


STAT+ | Deep cuts made to CDC’s flagship MMWR publication reversed hours later

Originally almost the entire staff of Morbidity and Mortality Weekly Report, known as the “voice of the CDC,” had been laid off.

By Chelsea Cirruzzo



Molly Ferguson for STAT

STAT+ | Opinion: Why this cardiologist is cautious about the Apple Watch’s blood pressure feature

The Apple Watch can’t decide if it’s a consumer-grade wearable or a medical-grade device, a cardiologist writes.

By Vishal Khetpal


STAT+ | Medicare Advantage insurers still in retreat as annual enrollment kicks off

Private Medicare insurers are increasingly paring back both the number of plans they offer and the benefits within those plans.

By Tara Bannow


Opinion: Drug developers shouldn’t shortchange the autoimmune community

Trial participants deserve financial and logistical help, radical transparency, and honesty about benefits and risks.

By Paul J. Hastings


The after-visit summary on Rocco Giuliano’s iPad inside his Boston apartment on Oct. 6. Giuliano, who doesn’t have a primary care physician, recently used an AI platform from Mass General Brigham to be referred to a doctor for a telehealth appointment.
Pat Greenhouse/Boston Globe

STAT+ | One Mass. health system is turning to AI to ease shortage of primary care doctors. Some don’t like it

The health care system's AI app questions patients, reviews medical records, and produces a list of potential diagnoses

By Jonathan Saltzman — Boston Globe


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.